AbbVie and Galderma Control 80% of Aesthetic Medicine's AI Citations, New 5W Index Finds

AbbVie and Galderma's control of 80% of aesthetic medicine's AI citations, as revealed by the new 5W Index, marks a significant concentration of online influence in the medical aesthetics industry. This development highlights the dominance of major pharmaceutical companies in shaping the online narrative around aesthetic medicine, potentially leaving independent med spas and smaller brands to compete for a limited share of visibility. For website owners in the medical aesthetics industry, this means that their online presence and content may be eclipsed by the dominant AI-driven marketing efforts of AbbVie and Galderma. As a result, they may need to reassess their SEO strategies and content creation approaches to remain competitive. The fact that 11,500 independent med spas are competing for only 5% of AI citation share underscores the challenges faced by smaller players in this industry. To stay ahead, website owners can take actionable steps such as monitoring their llms.txt files to ensure they are not inadvertently allowing AI bots from dominant companies to scrape their content, and adjusting their content policies to prioritize unique, high-quality information that can help them stand out. Additionally, they can leverage AI bot tracking tools to analyze the online activities of major pharmaceutical companies and identify potential gaps in the market that they can exploit to increase their own online visibility.